WHO Pharmaceuticals Newsletter 2005, No. 01
(2005; 12 pages) View the PDF document
Table of Contents
Close this folderREGULATORY MATTERS
View the documentAMIODARONE - Medication Guide to be dispensed along with medicine
View the documentATOMOXETINE - Labelling to include liver injury warning
View the documentBENZATHINE BENZYL-PENICILLIN/PROCAINEBENZYLPENICILLIN - Label changes highlight appropriate use
View the documentMEFLOQUINE - Patient Information Leaflet to help recognize adverse symptoms
View the documentPARACETAMOL-DEXTROPROP-OXYPHENE - To be withdrawn due to risk of toxicity in overdose
View the documentSMALLPOX VACCINE - Label to highlight reports of myopericarditis
View the documentTHIORIDAZINE - Withdrawn due to poor benefit/risk profile
Open this folder and view contentsSAFETY OF MEDICINES
Open this folder and view contentsDRUGS OF CURRENT INTEREST
Open this folder and view contentsFEATURE
 

MEFLOQUINE - Patient Information Leaflet to help recognize adverse symptoms

Canada. Hoffman-La Roche is introducing an updated Patient Information Leaflet in every box of mefloquine (Lariam), used in the prophylactic treatment of malaria. The updated leaflet

• is intended to help patients recognize symptoms, including the sudden onset of unexplained anxiety, depression, restlessness, irritability, confusion, a persistently abnormal heartbeat, or palpitations, that may precede rare but potentially serious psychiatric, neurologic, or cardiac adverse events;

• advises patients who develop these symptoms to contact a health-care professional to assess the need for discontinuation of Lariam® (mefloquine) treatment and,

• includes a wallet card containing a summary of the most essential information, that may be cut out and carried by the patient during travel to areas with malaria.


Reference:

'Dear Health-care Professional' letter from Hoffman-La Roche, 24 January 2005. Available on the Internet at www.hc-sc.gc.ca

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018